Increased Survival after Treatment of Canine Hemangiosarcoma with Fenofibrate
<p>Hemangiosarcoma (HSA) is a common and highly metastatic tumor that affects predominantly large-breed dogs. The median survival time for dogs diagnosed with splenic HSA without adjuvant chemotherapy after surgery is 86 days. Fenofibrate is an FDA-approved drug commonly utilized to treat high...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
International Journal of Veterinary Science and Research - Peertechz Publications,
2015-10-16.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|